HE vs NBIX · P/E 18, rev $799.2M vs P/E 45, rev $2.36B
Hawaiian Electric Industries Inc (HE) versus Neurocrine Biosciences Inc (NBIX) — a side-by-side from cached financials, not a winner call.
Hawaiian Electric Industries Inc (HE) is a utilities - regulated electric company listed on NYSE.
Neurocrine Biosciences Inc (NBIX) is a drug manufacturers - specialty & generic company listed on US.
Latest reported HE revenue for 2024-12-31 was $799.2M. Net income was -$1.42B. Revenue was down 4.1% from 2024-09-30 to 2024-12-31. HE currently screens at market cap $2.26B and trailing P/E 17.7.
Latest reported NBIX revenue for 2024-12-31 was $2.36B. Net income was $341.3M. Revenue was up 24.8% from 2023-12-31 to 2024-12-31. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
HE currently screens at market cap $2.26B and trailing P/E 17.7. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
Not investment advice. Open the HE and NBIX stock pages for the full models.
Not investment advice.